Page 1 of Clinical Trials for gp 100 209-217 210m, 16 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Injection Of AJCC Stage IIB, IIC, III And IV Melanoma Patients With A Multi-Epitope Peptide Vaccine Using GM-CSF DNA As An Adjuvant: A Pilot Trial To Assess Safety And Immunity
Last Updated: June 9, 2011
Condition(s): Melanoma
2
Completed
Evaluation of the Impact of Adjuvants Accompanying Peptide Immunization in High-Risk Melanoma
Last Updated: July 15, 2010
Condition(s): High-Risk Melanoma
3
Active, not recruiting
Melanoma Vaccine With Peptides and Leuprolide
Last Updated: October 17, 2011
Condition(s): Melanoma
4
Active, not recruiting
Ipilimumab With or Without Vaccine Therapy in Treating Patients With Previously Treated Stage IV Melanoma
Last Updated: February 6, 2009
Condition(s): Melanoma (Skin)
5
Completed
Fludarabine Followed by Vaccine Therapy and White Blood Cell Infusions in Treating Patients With Unresectable or Metastatic Melanoma
Last Updated: March 25, 2010
Condition(s): Melanoma (Skin)
6
Completed
Adesleukin With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Melanoma
Last Updated: October 11, 2011
Condition(s): Melanoma (Skin)
7
Completed
Peptide Vaccination for Patients at High Risk for Recurrent Melanoma
Last Updated: March 16, 2011
Condition(s): Melanoma
8
Completed
Vaccine Therapy in Treating Patients With Metastatic Melanoma of the Eye
Last Updated: March 2, 2007
Condition(s): Extraocular Extension Melanoma; Recurrent Intraocular Melanoma
9
Completed
Vaccine Therapy With High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma
Last Updated: February 6, 2009
Condition(s): Melanoma (Skin)
10
Completed
Vaccine Therapy in Treating Patients With Metastatic Melanoma
Last Updated: May 13, 2010
Condition(s): Intraocular Melanoma; Melanoma (Skin)
11
Completed
Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
Last Updated: December 14, 2011
Condition(s): Intraocular Melanoma; Malignant Conjunctival Neoplasm; Melanoma (Skin)
12
Completed
Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma
Last Updated: July 15, 2010
Condition(s): Melanoma; Neoplasm Metastasis
13
Recruiting
Vaccine Therapy and Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
Last Updated: October 6, 2010
Condition(s): Melanoma (Skin)
14
Recruiting
Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Stage IV Melanoma That Has Been Removed By Surgery
Last Updated: September 27, 2011
Condition(s): Melanoma (Skin)
15
Completed
Immunization of Patients With Metastatic Melanoma Using the GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence
Last Updated: March 3, 2008
Condition(s): Melanoma; Neoplasm Metastasis
16
Completed
Phase I/II Study of Chemo-Immunotherapy Combination in Melanoma Patients
Last Updated: November 15, 2007
Condition(s): Melanoma

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=gp+100+209-217+210m

Page 1 of Clinical Trials for gp 100 209-217 210m, 16 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About